Related Experiment Videos
Immunotherapy for autoimmune and inflammatory renal diseases
1Division of Renal Medicine, St George's Hospital Medical School, London, UK. djayne@sghms.ac.uk
Current Opinion in Nephrology and Hypertension
|June 9, 1998
Summary
New immunotherapy strategies show promise for autoimmune kidney diseases. Research is exploring treatments like immunoglobulin therapy, lymphocyte depletion, and novel antibody-based approaches for better patient outcomes.
Area of Science:
- Nephrology
- Immunology
- Rheumatology
Background:
- Autoimmune renal diseases require novel therapeutic strategies.
- Understanding immunopathogenesis reveals potential immunotherapy targets.
- Existing treatments for related conditions like vasculitis and lupus erythematosus offer insights.
Purpose of the Study:
- To review current and emerging immunotherapies for autoimmune renal diseases.
- To highlight treatments advancing towards clinical validation.
- To discuss the potential of novel immunomodulatory approaches.
Main Methods:
- Review of existing literature on immunopathogenesis and treatment of autoimmune renal diseases.
- Analysis of clinical trial data for intravenous immunoglobulin and monoclonal antibodies.
- Evaluation of novel therapeutic strategies including antibody blockade and stem cell transplantation.
Main Results:
- Intravenous immunoglobulin and lymphocyte depletion show potential but require randomized trial confirmation.
- Monoclonal antibody therapies targeting leukocyte-endothelial interactions and B-cell activation are in development.
- Immunoablation with autologous stem-cell transplantation is an option for severe cases.
Conclusions:
- Immunotherapy holds significant promise for treating autoimmune renal diseases.
- Targeted immunomodulation represents a key area for future treatment development.
- Further clinical trials are essential to validate the efficacy and safety of these new treatments.